Skip to main content
. 2017 Dec 1;9:95. doi: 10.1186/s13098-017-0293-2

Fig. 1.

Fig. 1

Adiponectin (a), resistin (b) and adiponectin–resistin (AR) index (c) in sera of obese and normal-weight individuals. Comparison of resistin serum levels in individuals stratified according to presence of hypertension (d) and metabolic syndrome (MS, e). Comparison of adiponectin–resistin (AR) index in obese individuals stratified according to presence of MS (f). Results are presented as mean ± standard deviation